Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8161 Cr | ₹2652 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 15% |
Expense Ratio | 1.82 | 1.92 |
Manager | Sailesh Raj Bhan | Vrijesh Kasera |
ISIN Code | INF204K01968 | INF769K01EA2 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | 6.54% | 9.05% |
6 Month | -8.15% | -7.09% |
1 Year | 12.22% | 17.24% |
3 Year | 18.67% | 17.98% |
5 Year | 28.38% | 28.96% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | -4.43% | -3.4% |
1 Year | -0.48% | 3.98% |
3 Year | 22.66% | 23.76% |
5 Year | 19.18% | 19.66% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 18.19% | 24.74% |
3 Year | 20.5% | 19.07% |
5 Year | 20.36% | 24.52% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.623% | 16.629% |
Sharp | 0.707% | 0.604% |
Beta | 0.908% | 0.974% |
Alpha | 0.486% | -1.264% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Sailesh Raj Bhan | Vrijesh Kasera |
Total AUM | ₹96086 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 2.93 |
Large Cap | 38.72 | 34.72 |
Mid Cap | 32.78 | 39.03 |
Small Cap | 27.14 | 23.32 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.36 | 0.17 |
Healthcare | 98.64 | 98.36 |
Basic Materials | - | 0.74 |
Industrials | - | 0.73 |
Top Comparisons
HSBC Medium to Long Duration Fund - Regular Growth
3Y Returns5.51%
Canara Robeco Income Fund - Regular Plan - Growth Option
3Y Returns5.72%
UTI Low Duration Fund- Discontinued Growth Option
3Y Returns6.34%
UTI Low Duration Fund - Regular Plan - Growth Option
3Y Returns6.76%
Aditya Birla Sun Life Focused Equity Fund -Growth Option
3Y Returns13.89%
Mirae Asset Focused Fund Regular Plan Growth
3Y Returns7.7%
Edelweiss Small Cap Fund - Regular Plan - Growth
3Y Returns16.9%
Quant Small Cap Fund Regular Growth
3Y Returns21.15%